Hai Jia International Limited Company (HBIE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2004 | 2003 |
|---|---|---|---|---|---|---|
| Revenue | 24.84 Thousand | - | - | - | - | - |
| Cost of Revenue | 40.16 Thousand | - | - | - | - | - |
| Gross Profit | -15.31 Thousand | - | - | - | - | - |
| Operating Expenses | 41.13 Thousand | 24.15 Thousand | 15.51 Thousand | 513.00 | - | 14.9 Thousand |
| Selling, General and Administrative Expenses | - | - | - | - | - | 14.9 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 41.13 Thousand | -24.15 Thousand | -15.51 Thousand | -513.00 | - | - |
| Cost and Expenses | 81.29 Thousand | 24.15 Thousand | 15.51 Thousand | 513.00 | - | 14.9 Thousand |
| Operating Income | -56.45 Thousand | -24.15 Thousand | -15.51 Thousand | -513.00 | -24.34 Thousand | -14.9 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 1289.00 | - | - | - | 24.34 Thousand | 11.00 |
| Earnings before Tax | -56.45 Thousand | -24.15 Thousand | -14.72 Thousand | 705.00 | - | -14.63 Thousand |
| Net Income | -57.74 Thousand | -24.15 Thousand | -14.72 Thousand | 705.00 | -24.34 Thousand | -14.63 Thousand |
| Earnings Per Share Basic | - | - | - | - | -0.03 | -0.02 |
| Earnings Per Share Diluted | - | - | - | - | -0.03 | -0.02 |
| Weighted Average Shares Outstanding | 1.23 Billion | 1.23 Billion | 371.05 Million | 70.11 Million | 800 Thousand | 742.3 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.23 Billion | 1.23 Billion | 371.05 Million | 70.11 Million | 800 Thousand | 742.3 Thousand |
| Gross Margin | -0.62 | - | - | - | - | - |
| EBIT Margin | -2.27 | - | - | - | - | - |
| Profit Margin | -2.32 | - | - | - | - | - |
| EBITDA | -56.45 Thousand | -24.15 Thousand | -14.72 Thousand | 704.00 | -24.34 Thousand | -15.18 Thousand |
| Earnings Before Tax Margin | -2.27 | - | - | - | - | - |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2004 Q4 | 2004 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 19.44 Thousand | 5408.00 | - | - |
| Cost of Revenue | -63.00 | 4021.00 | 39.5 Thousand | 667.00 | - | - |
| Gross Profit | 63.00 | -4021.00 | -20.06 Thousand | 4741.00 | - | - |
| Operating Expenses | 21.7 Thousand | 19.13 Thousand | -41.28 Thousand | 65.35 Thousand | - | - |
| Selling, General and Administrative Expenses | - | - | - | - | - | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -21.7 Thousand | -19.13 Thousand | 41.28 Thousand | -65.35 Thousand | - | - |
| Cost and Expenses | 21.63 Thousand | 23.15 Thousand | -1786.00 | 66.01 Thousand | - | - |
| Operating Income | -21.63 Thousand | -23.15 Thousand | 21.22 Thousand | -60.61 Thousand | - | - |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | - | 1289.00 | - | - | - |
| Earnings before Tax | -21.63 Thousand | -23.15 Thousand | 21.22 Thousand | -60.25 Thousand | - | - |
| Net Income | -21.63 Thousand | -23.15 Thousand | 19.93 Thousand | -60.25 Thousand | - | - |
| Earnings Per Share Basic | - | - | - | - | - | - |
| Earnings Per Share Diluted | - | - | - | - | - | - |
| Weighted Average Shares Outstanding | 1.23 Billion | 1.23 Billion | 1.23 Billion | 1.23 Billion | 10.11 Million | 10.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.23 Billion | 1.23 Billion | 1.23 Billion | 1.23 Billion | 10.11 Million | 10.11 Million |
| Gross Margin | - | - | -1.03 | 0.88 | - | - |
| EBIT Margin | - | - | 1.09 | -11.21 | - | - |
| Profit Margin | - | - | 1.03 | -11.14 | - | - |
| EBITDA | -21.63 Thousand | -23.15 Thousand | 21.22 Thousand | -60.61 Thousand | - | - |
| Earnings Before Tax Margin | - | - | 1.09 | -11.21 | - | - |
032350
DIABIO
GENPHARMA
SVIIW
GGAAF
QBAT